Literature DB >> 27493078

A highly reproducible mice model of chronic kidney disease: Evidences of behavioural abnormalities and blood-brain barrier disruption.

Muhammed Khairujjaman Mazumder1, Anirudha Giri2, Sanjeev Kumar3, Anupom Borah4.   

Abstract

AIMS: In the present study, a novel mice model of chronic kidney disease (CKD) was developed, and psycho-motor behavioural abnormalities, blood-brain barrier (BBB) integrity and brain histology were studied. MAIN
METHODS: Swiss albino female mice were given high adenine diet (0.3% w/w mixed with feed) for 4weeks. Serum urea and creatinine levels and renal histological studies were performed to validate the model. Psycho-motor behavioural abnormalities and neurological severity were studied. BBB integrity was assessed using Evans blue extravasation method. Nissl staining was performed to see possible morphological aberrations in brain. KEY
FINDINGS: There was a significant increase in serum urea and creatinine levels in mice given high adenine diet, and the mice had abnormal kidney morphology. Deposition of adenine and 2,8-dihydroxyadenine crystals, and increased collagen deposits in the renal tissues were found, which validate induction of CKD in the mice. Motor behavioural abnormalities, depression-like and anxiolytic behaviour and increase in neurological severity were prevalent in mice with CKD. Evans Blue dye extravasation was found to occur in the brain, which signifies disruption of BBB. However, Nissl staining did not reveal any morphological aberration in brain tissue. SIGNIFICANCE: The present study puts forward a highly reproducible mice model of CKD validated with serum parameters and renal histopathological changes. The mice showed psycho-motor behavioural abnormalities and BBB disruption. It is a convenient model to study the disease pathology, and understanding the associated disorders, and their therapeutic interventions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic renal failure; End-stage renal disease; Evans blue dye; Picro-Sirius red staining; Psycho-motor behaviour; Renal fibrosis

Mesh:

Substances:

Year:  2016        PMID: 27493078     DOI: 10.1016/j.lfs.2016.07.020

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.

Authors:  Mickaël Bobot; Laurent Thomas; Anaïs Moyon; Samantha Fernandez; Nathalie McKay; Laure Balasse; Philippe Garrigue; Pauline Brige; Sophie Chopinet; Stéphane Poitevin; Claire Cérini; Philippe Brunet; Françoise Dignat-George; Stéphane Burtey; Benjamin Guillet; Guillaume Hache
Journal:  J Am Soc Nephrol       Date:  2020-06-11       Impact factor: 10.121

2.  Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier.

Authors:  Wanghui Jing; Bahman Jabbari; Nosratola D Vaziri
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 3.  The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.

Authors:  Tao Yang; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  Nat Rev Nephrol       Date:  2018-07       Impact factor: 28.314

Review 4.  Linking chronic kidney disease and Parkinson's disease: a literature review.

Authors:  Jesús D Meléndez-Flores; Ingrid Estrada-Bellmann
Journal:  Metab Brain Dis       Date:  2020-09-29       Impact factor: 3.584

5.  Global loss of acetylcholinesterase activity with mitochondrial complexes inhibition and inflammation in brain of hypercholesterolemic mice.

Authors:  Rajib Paul; Anupom Borah
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

6.  Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.

Authors:  Rajib Paul; Amarendranath Choudhury; Sanjeev Kumar; Anirudha Giri; Rajat Sandhir; Anupom Borah
Journal:  PLoS One       Date:  2017-02-07       Impact factor: 3.240

7.  Skeletal myopathy in CKD: a comparison of adenine-induced nephropathy and 5/6 nephrectomy models in mice.

Authors:  Kyoungrae Kim; Erik M Anderson; Trace Thome; Guanyi Lu; Zachary R Salyers; Tomas A Cort; Kerri A O'Malley; Salvatore T Scali; Terence E Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2021-06-14

8.  A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease.

Authors:  Bartlomiej Kalaska; Krystyna Pawlak; Ewa Oksztulska-Kolanek; Tomasz Domaniewski; Beata Znorko; Malgorzata Karbowska; Aleksandra Citkowska; Joanna Rogalska; Alicja Roszczenko; Malgorzata M Brzoska; Dariusz Pawlak
Journal:  PeerJ       Date:  2017-04-20       Impact factor: 2.984

9.  Chronic kidney disease exacerbates ischemic limb myopathy in mice via altered mitochondrial energetics.

Authors:  Fabian N Berru; Sarah E Gray; Trace Thome; Ravi A Kumar; Zachary R Salyers; Madeline Coleman; Kerri O'Malley; Leonardo F Ferreira; Scott A Berceli; Salvatore T Scali; Terence E Ryan
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

10.  Female AhR Knockout Mice Develop a Minor Renal Insufficiency in an Adenine-Diet Model of Chronic Kidney Disease.

Authors:  Camélia Makhloufi; Fanny Nicolas; Nathalie McKay; Samantha Fernandez; Guillaume Hache; Philippe Garrigue; Philippe Brunet; Benjamin Guillet; Stéphane Burtey; Stéphane Poitevin
Journal:  Int J Mol Sci       Date:  2020-04-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.